MedPath
HSA Approval

SW-BENA PAEDIATRIC EXPECTORANT

SIN07609P

SW-BENA PAEDIATRIC EXPECTORANT

SW-BENA PAEDIATRIC EXPECTORANT

January 14, 1994

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R05FB02

cough suppressants and expectorants

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

SODIUM CITRATE

50 mg/5 ml

Sodium citrate

DIPHENHYDRAMINE HCl

5 mg/5 ml

Diphenhydramine

AMMONIUM CHLORIDE

62.5 mg/5 ml

Ammonium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SW-BENA PAEDIATRIC EXPECTORANT - HSA Approval | MedPath